PMV Pharmaceuticals, Inc. (PMVP) stock
PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.27+0.06 (+4.96%)
Close on Nov 13, 2026Market cap $67.89MP/E –Yield –
PMV Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
PMV Pharmaceuticals's enterprise value was -$12.07M on Nov 11, 2026, against -$59.30M a year earlier. Over the last 5 years it ranged from -$149.17M to $739.98M, with a median of -$34.35M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$12.07M | – |
| 2025 | Dec 31, 2025 | -$63.01M | – |
| 2024 | Dec 31, 2024 | -$119.80M | – |
| 2023 | Dec 29, 2023 | -$79.51M | -157.6% |
| 2022 | Dec 30, 2022 | $138.08M | -81.3% |
| 2021 | Dec 31, 2021 | $739.98M | -68.9% |
| 2020 | Dec 31, 2020 | $2.38B | – |
See a number that looks wrong?